ETROLIZUMAB AS INDUCTION THERAPY IN MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM BERGAMOT COHORT 1

William Sandborn  1     Julian Panés  2     Jennifer Jones  3     Azra Hassanali  4     Rhian Jacob  5     Zaineb Sharafali  6     Young S. Oh     Swati Tole    
1 University of California, San Diego,La Jolla,United States of America
2 Hospital Clínic of Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 Queen Elizabeth II Health Sciences Center,Halifax,Canada
4 Genentech, Inc.,South San Francisco,United States of America
5 Roche Products Limited,Welwyn Garden City,United Kingdom
6 Genentech, Inc.,South

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing